{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:10:50Z","timestamp":1793913050946,"version":"4.8.0"},"reference-count":21,"publisher":"American Medical Association (AMA)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,10,5]]},"DOI":"10.1001\/jama.2021.14785","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T04:02:50Z","timestamp":1633579370000},"page":"1268","source":"Crossref","is-referenced-by-count":47,"title":["Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life"],"prefix":"10.1001","volume":"326","author":[{"given":"Harri\u00ebtte J.","family":"van Esch","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands"},{"name":"Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands"},{"name":"Laurens Cadenza, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"van Zuylen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands"},{"name":"Department of Medical Oncology, Amsterdam University Medical Centers, Cancer Center Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C. T.","family":"Geijteman","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oomen-de Hoop","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bregje A. A.","family":"Huisman","sequence":"additional","affiliation":[{"name":"Hospice Kuria, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike S.","family":"Noordzij-Nooteboom","sequence":"additional","affiliation":[{"name":"Hospice Calando, Dirksland, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske","family":"Boogaard","sequence":"additional","affiliation":[{"name":"Palliative Care Unit \u201cde Regenboog,\u201d Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"van der Heide","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin C. D.","family":"van der Rijt","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"joi210093r1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpainsymman.2013.03.011","article-title":"Prevalence, impact, and treatment of death rattle: a systematic review.","volume":"47","author":"Lokker","year":"2014","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"joi210093r2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1191\/0269216302pm584oa","article-title":"Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care.","volume":"16","author":"Bennett","year":"2002","journal-title":"Palliat Med"},{"issue":"1","key":"joi210093r3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1191\/026921600670897377","article-title":"Risk factors for death rattle in terminally ill cancer patients: a prospective exploratory study.","volume":"14","author":"Morita","year":"2000","journal-title":"Palliat Med"},{"issue":"3","key":"joi210093r4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1191\/0269216306pm1137oa","article-title":"The sound of death rattle, I: are relatives distressed by hearing this sound?","volume":"20","author":"Wee","year":"2006","journal-title":"Palliat Med"},{"issue":"1","key":"joi210093r5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jpainsymman.2013.07.010","article-title":"Care strategy for death rattle in terminally ill cancer patients and their family members: recommendations from a cross-sectional nationwide survey of bereaved family members\u2019 perceptions.","volume":"48","author":"Shimizu","year":"2014","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"joi210093r6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40359-020-00431-3","article-title":"Understanding relatives\u2019 experience of death rattle.","volume":"8","author":"van Esch","year":"2020","journal-title":"BMC Psychol"},{"key":"joi210093r9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-2002-24628","article-title":"A clinical study examining the efficacy of scopolamine-hydrobromide in patients with death rattle (a randomized, double-blind, placebo-controlled study).","volume":"3","author":"Likar","year":"2002","journal-title":"Zeitschrift fuer Palliativmedizin"},{"issue":"1","key":"joi210093r10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jpainsymman.2012.01.006","article-title":"Randomized double-blind trial of sublingual atropine vs placebo for the management of death rattle.","volume":"45","author":"Heisler","year":"2013","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"joi210093r11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00520-013-2047-5","article-title":"Death rattle: critical review and research agenda.","volume":"22","author":"Mercadamte","year":"2014","journal-title":"Support Care Cancer"},{"issue":"6","key":"joi210093r12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jpainsymman.2018.08.018","article-title":"Hyoscine butylbromide for the Management of death rattle: sooner rather than later.","volume":"56","author":"Mercadante","year":"2018","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"joi210093r13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12904-018-0359-4","article-title":"Scopolaminebutyl given prophylactically for death rattle: study protocol of a randomized double-blind placebo-controlled trial in a frail patient population (the SILENCE study).","volume":"17","author":"van Esch","year":"2018","journal-title":"BMC Palliat Care"},{"issue":"7379","key":"joi210093r14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/bmj.326.7379.30","article-title":"Care of the dying patient: the last hours or days of life.","volume":"326","author":"Ellershaw","year":"2003","journal-title":"BMJ"},{"issue":"4","key":"joi210093r15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1191\/026921601678320313","article-title":"A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle.","volume":"15","author":"Back","year":"2001","journal-title":"Palliat Med"},{"issue":"9","key":"joi210093r17","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S0895-4356(00)00208-0","article-title":"Measuring quality of sedation in adult mechanically ventilated critically ill patients: the Vancouver Interaction and Calmness Scale.","volume":"53","author":"de Lemos","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"joi210093r18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/bmjspcare-2018-001729","article-title":"Hydration and symptoms in the last days of life.","volume":"11","author":"Lokker","year":"2019","journal-title":"BMJ Support Palliat Care"},{"issue":"446","key":"joi210093r19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J AM Stat Assoc"},{"issue":"1","key":"joi210093r20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jpainsymman.2008.07.007","article-title":"Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care.","volume":"38","author":"Wildiers","year":"2009","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"joi210093r21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3109\/15360288.2010.493579","article-title":"Research in end-of-life settings: an ethical inquiry.","volume":"24","author":"LeBlanc","year":"2010","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"joi210093r7","unstructured":"National Institute for Health and Care Excellence. NICE guideline NG 31: care of dying adults in the last days of life. Published December 16, 2015. Accessed October 22, 2020. https:\/\/www.nice.org.uk\/guidance\/ng31?"},{"key":"joi210093r8","unstructured":"van Zuylen? L, van Veluw? H, van Esch? HJ. Care for the dying, national guideline. Netherlands Comprehensive Cancer Organization. Publication in Dutch. Published 2010. Accessed October 22, 2020. https:\/\/www.pallialine.nl\/stervensfase?"},{"key":"joi210093r16","unstructured":"Netherlands Comprehensive Cancer organization. Zorgpad Stervensfase (kennisclip). Video in Dutch. Palliaweb. 2019. Accessed October 22, 2020. https:\/\/palliaweb.nl\/onderwijsmaterialen\/zorgpad-stervensfase"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2784661\/jama_van_esch_2021_oi_210093_1633385134.18283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T04:02:55Z","timestamp":1633579375000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2784661"}},"subtitle":["The SILENCE Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":21,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,10,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.14785","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740933757.793591388","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,5]]}}}